Mediomics Lands $460K STTR Grant | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mediomics has reeled in $460,000 from the National Institute of General Medical Sciences through a Phase II Small Business Technology Transfer (STTR) grant.

The company plans to use the funds to develop and increase the sensitivity of its biosensor technology and to develop its PINCER protein assay. Mediomics is commercializing core technologies it has licensed under an exclusive agreement with Saint Louis University.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.